Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens
暂无分享,去创建一个
Takeshi Takahashi | I. Yasuda | M. Shimizu | H. Moriwaki | T. Takami | T. Yoshikawa | H. Tsurumi | S. Kasahara | Naoe Goto | T. Hara | N. Murakami | Yusuke Kito | H. Goto | K. Fukuno | Y. Shimomura